Status:
WITHDRAWN
Exercise Interventions in Post-acute Sequelae of Covid-19
Lead Sponsor:
University of Virginia
Conditions:
COVID-19
Eligibility:
All Genders
18-50 years
Phase:
NA
Brief Summary
The COVID-19 pandemic severely impacted the medical system both directly but also through incomplete recovery from the virus in the form of post-acute sequelae of COVID-19 (PASC). PASC affects at leas...
Eligibility Criteria
Inclusion
- 18-50 years of age
- Diagnosed with Post Acute Sequelae of COVID-19
- Physician clearance to undergo exercise training (see section titled cardiorespiratory fitness testing for details; page 6)
- Complete COVID-19 vaccination status
Exclusion
- Unstable angina or myocardial infarction in the past 4 weeks
- Uncompensated heart failure
- NYHA class IV symptoms
- Complex ventricular arrhythmias
- Musculoskeletal contraindications to stationary bicycling exercise
- Symptomatic severe aortic stenosis
- Acute pulmonary embolus
- Acute myocarditis
- Uncontrolled Hypertension as defined as systolic blood pressure \> 180 mm Hg or diastolic blood pressure \> 120 mm Hg
- Medication non-compliance
- Pregnant women-self reported
- COPD GOLD stage D
- Malignancy currently actively being treated
- Uncontrolled Asthma
- Uncompensated Cirrhosis of the Liver
- Chronic Kidney disease requiring dialysis therapy
- Symptomatic Anemia
- Hemoglobin \<7g/dL
- Poorly controlled diabetes or A1c\>9%
- BMI \>35kg/m2
- Pulmonary Hypertension stage IV
- Any condition requiring supplemental oxygen
- Multiple Sclerosis
Key Trial Info
Start Date :
September 9 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 29 2024
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT06065033
Start Date
September 9 2023
End Date
March 29 2024
Last Update
May 8 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Virginia University Hospital
Charlottesville, Virginia, United States, 22903